ADN Signals
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (8 quarters)
●Pre-revenue with moderate cash ($10-30M)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week low (5% of range)
●Small-cap ($20-100M)
NMR Signals
●MACD crossed bearish — momentum is fading
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.0 quarters)
●Low P/S ratio (4.7x)
●Strong revenue growth (+328720%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Near 52-week low (4% of range)
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).